Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma OncLive
Regulatory Approvals
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma Targeted Oncology
FDA Issues Emergency Use Authorization for Drug to Treat New World Screwworm in Dogs and Puppies
The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Simparica TRIO (sarolaner, moxidectin, and pyrantel…
Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and …
Spero Therapeutics Inc (SPRO) (Q2 2026) Earnings Call Highlights: FDA Approval of Utebzi and ... Yahoo Finance
What Does the FDA Approval of Orally Disintegrating Nilotinib Tablets Mean for CML Practice?
What Does the FDA Approval of Orally Disintegrating Nilotinib Tablets Mean for CML Practice? OncLive